Results 111 to 120 of about 4,860 (160)

Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis. [PDF]

Hepatobiliary Surg Nutr
Chen CL, Dungca LBP, Yong CC, Chen IC, Cheng YF.   +4 more
europepmc   +1 more source

Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma. [PDF]

World J Radiol
Hao K, Paik AJ, Han LH, Makary MS.
europepmc   +1 more source

Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas. [PDF]

Cancers (Basel), 2022
Testa S, Bui NQ, Wang DS, Louie JD, Sze DY, Ganjoo KN.   +5 more
europepmc   +1 more source

Systemic Immunological Changes After Yttrium-90 Radioembolization: A Pilot Prospective Observational Study-Clinical Insights. [PDF]

Cardiovasc Intervent Radiol
Kitsel Y, Petre EN, Wong P, Sotirchos V, Vakiani E, Dimopoulos PM, Ganesh K, Rousseau B, Sofocleous CT.   +8 more
europepmc   +1 more source

Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study. [PDF]

J Hepatocell Carcinoma, 2021
Kim MA, Jang H, Choi NR, Nam JY, Lee YB, Cho EJ, Lee JH, Yu SJ, Kim HC, Chung JW, Yoon JH, Kim YJ.   +11 more
europepmc   +1 more source

Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases. [PDF]

JCEM Case Rep
Hamidi S, Mahvash A, Hu MI.
europepmc   +1 more source

A comparison of methods for in vivo activity and absorbed dose quantification with PET/CT following yttrium-90 radioembolization. [PDF]

Med Phys
Henry EC, Mahvash A, Lopez BP, Kappadath SC.   +3 more
europepmc   +1 more source

Prognostic value of CT-based skeletal muscle and adipose tissue mass and quality parameters in patients with liver metastases and intrahepatic cholangiocarcinoma undergoing Yttrium-90 radioembolization. [PDF]

Eur Radiol
Zhao Y, Becce F, Balmer R, do Amaral RH, Alemán-Gómez Y, Uldry E, Fraga M, Tsoumakidou G, Villard N, Denys A, Digklia A, Schaefer N, Duran R.   +12 more
europepmc   +1 more source

Erratum: Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. [PDF]

Semin Intervent Radiol, 2020
Villalobos A, Soliman MM, Majdalany BS, Schuster DM, Galt J, Bercu ZL, Kokabi N.   +6 more
europepmc   +1 more source

Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma [PDF]

, 2014
Arndt Weinmann, Christian Ruckes, Christoph Dueber, Gerd Otto, Gesine M. Wirth, Marcus A. Wörns, Mathias Schreckenberger, Michael B. Pitton, Peter R. Galle, Roman Kloeckner, Waltraud Eichhorn   +10 more
core   +1 more source